Contraception with subdermal ST-1435 capsules: Side-effects, endocrine profiles and liver function related to different lengths of capsules-Reference-Cited by-同舟云学术

Contraception with subdermal ST-1435 capsules: Side-effects, endocrine profiles and liver function related to different lengths of capsules

Published:1985-03 Issue:3 Volume:31 Page:305-318
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Kurunmäki Henri,Toivonen Juhani,Lähteenmäki Pertti,Luukkainen Tapani

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference15 articles.

1. Single administration of hormones for long-term control of reproductive function;Segal,1967

2. Contraception with subdermal implants containing gestagens. Plasma levels of d-norgestrel and megestrol acetate and effects on the ovarian steroid pattern;Weiner,1976

3. One-year contraception with norgestrienone subdermal Silastic implants;Coutinho;Fertil. Steril,1974

4. Contraceptive effectiveness of Silastic implants containing the progestin R2323;Coutinho;Contraception,1975

5. Preliminary report on the contraceptive use of subdermal implants containing norethindrone;Tejuja;Contraception,1974

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endometrial histology, microvascular density and caliber, and matrix metalloproteinase-3 in users of the Nestorone®-releasing contraceptive implant with and without endometrial breakthrough bleeding;Contraception;2006-06

2. Two-year performance of a Nestorone®-releasing contraceptive implant: a three-center study of 300 women;Contraception;2004-02

3. Recent developments in contraceptive implants at the Population Council;Contraception;2002-01

4. Metabolic effects of implantable steroid contraceptives for women;Contraception;2002-01

5. Mechanisms that explain the contraceptive action of progestin implants for women;Contraception;2002-01